Xinyan Chen

Celastrol-loaded galactosylated liposomes effectively inhibit AKT/c-Met-triggered rapid hepatocarcinogenesis in mice.

Zhenpeng Qiu, M. Yuan, Junjie Hu, 2020, Molecular pharmaceutics.

Cabozantinib-based combination therapy for the treatment of hepatocellular carcinoma

D. Calvisi, Xin Chen, Meng Xu, 2020, Gut.

The preparation, characterization of Lupeol PEGylated liposome and its functional evaluation in vitro as well as pharmacokinetics in rats

Zhenpeng Qiu, Junjie Hu, Guohua Zheng, 2019, Drug development and industrial pharmacy.

CDK9 is dispensable for YAP‐driven hepatoblastoma development

D. Calvisi, Xin Chen, S. Zhong, 2020, Pediatric blood & cancer.

Loss of Fbxw7 synergizes with activated AKT signaling to promote c-Myc dependent cholangiocarcinogenesis.

D. Calvisi, Xin Chen, A. Cossu, 2019, Journal of hepatology.

The development and evaluation of hyaluronic acid coated mitochondrial targeting liposomes for celastrol delivery

Junjie Hu, Guohua Zheng, Siying Huang, 2023, Drug delivery.

Alpelisib combination treatment as novel targeted therapy against hepatocellular carcinoma

D. Calvisi, Xin Chen, Hongwei Xu, 2021, Cell Death & Disease.